Sugi Predict

Sugi Predict / Targets / UBQLN2

UBQLN2

Ubiquilin-2 · Q9UHD9 · UBQLN2 on Sugi Atlas →

0 patent compounds predicted against UBQLN2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBQLN2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS) PHASE1RECRUITING
Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS) nanUNKNOWN
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS nanRECRUITING
A Natural History Study of Angelman Syndrome nanRECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Stakeholders of Rare Diseases Informing Values In Neuroethics nanRECRUITING
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Identification of New FTLD Genes nanUNKNOWN
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Amyotrophic Lateral Sclerosis (ALS) Families Project nanRECRUITING
The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study nanRECRUITING
Gene Analysis of Parkinson's Disease nanCOMPLETED
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
New Strategies of Genetic Study of Patients With Oculocutaneous Albinism nanCOMPLETED
Characterization of Angelman Syndrome nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Phenotype/Genotype Correlations in Neuromuscular Disorders nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Advancing Neurogenetic Diagnoses Through Long-Read Sequencing nanNOT_YET_RECRUITING
Pleiotropy and Mechanism of Peripheral Nerve Related Genes in the Progression of Amyotrophic Lateral Sclerosis nanUNKNOWN
Study of Proteus Syndrome and Related Congenital Disorders nanRECRUITING
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia nanUNKNOWN
ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study nanACTIVE_NOT_RECRUITING
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Myotubular and Centronuclear Myopathy Patient Registry nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a UBQLN2 binder may also engage these)

ProteinNameSimilarity
Q8R317 — 0.996 Q8R317 →
Q9QZM0 — 0.995 Q9QZM0 →
Q99NB8 — 0.994 Q99NB8 →
UBQLN1 Ubiquilin-1 0.993 landscape →
Q9SII9 — 0.991 Q9SII9 →
Q5R684 — 0.991 Q5R684 →
Q9NRR5 — 0.989 Q9NRR5 →
Q9JJP9 — 0.989 Q9JJP9 →
Q9SII8 — 0.981 Q9SII8 →
Q10169 — 0.979 Q10169 →
Q9NIF3 — 0.978 Q9NIF3 →
Q84L32 — 0.975 Q84L32 →
G5EFF7 — 0.975 G5EFF7 →
Q84L33 — 0.973 Q84L33 →
Q4KMA2 — 0.968 Q4KMA2 →
Q84L31 — 0.967 Q84L31 →
Q96S82 — 0.967 Q96S82 →
Q40742 — 0.967 Q40742 →
P54726 — 0.967 P54726 →
A3KMV2 — 0.966 A3KMV2 →
P48510 — 0.963 P48510 →
P54725 — 0.963 P54725 →
Q6NYI0 — 0.962 Q6NYI0 →
O74803 — 0.962 O74803 →
RAD23B UV excision repair protein RAD23 homolog B 0.961 landscape →
Q9YHD3 — 0.961 Q9YHD3 →
Q84L30 — 0.961 Q84L30 →
Q6PA26 — 0.961 Q6PA26 →
Q2KIS3 — 0.961 Q2KIS3 →
Q6MG49 — 0.960 Q6MG49 →